CN104569275A - Method for simultaneously measuring concentrations of monomer components including ursolic acid, schizandrin a, schizandrin b and schizandrin c - Google Patents

Method for simultaneously measuring concentrations of monomer components including ursolic acid, schizandrin a, schizandrin b and schizandrin c Download PDF

Info

Publication number
CN104569275A
CN104569275A CN201510036874.7A CN201510036874A CN104569275A CN 104569275 A CN104569275 A CN 104569275A CN 201510036874 A CN201510036874 A CN 201510036874A CN 104569275 A CN104569275 A CN 104569275A
Authority
CN
China
Prior art keywords
fruit
ursolic acid
schizandrin
concentration
peak area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510036874.7A
Other languages
Chinese (zh)
Other versions
CN104569275B (en
Inventor
刘宏胜
王树森
刘洪利
张雅敏
沈中阳
夏爽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin First Central Hospital
Original Assignee
Tianjin First Central Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin First Central Hospital filed Critical Tianjin First Central Hospital
Priority to CN201510036874.7A priority Critical patent/CN104569275B/en
Publication of CN104569275A publication Critical patent/CN104569275A/en
Application granted granted Critical
Publication of CN104569275B publication Critical patent/CN104569275B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention discloses a method for simultaneously measuring the concentrations of monomer components including ursolic acid, schizandrin a, schizandrin b and schizandrin c, belonging to material analysis by using a chromatography. The method disclosed by the invention comprises the following steps: respectively preparing a mixed sample of dogwood and schisandra chinensis and a negative control solution of a sample to be measured, and, after pre-processing, carrying out preparation of a working curve and chromatographic separation and content determination of the four monomer components under the conditions as follows: a mobile phase is the mixture of acetonitrile and 0.1% phosphoric acid aqueous solution with the ratio of 67 to 33; the volume flow rate is 0.8-1.2 mL/min; the ultraviolet detection wavelength is 190-220 nm; and the column temperature is 25-40 DEG C. Simultaneous concentration detection and complete separation of the four monomer components including ursolic acid, schizandrin a, schizandrin b and schizandrin c are realized within a relatively short time under same wavelength chromatographic experimental conditions; the method disclosed by the invention has the advantages of being steady in base line, symmetrical and attractive in peak pattern, simple, convenient, rapid, high in separation degree and sensitivity, good in repeatability, accurate and reliable in data and high in recovery; and therefore, a good quality control detection method is provided.

Description

The method of Simultaneously test ursolic acid and the fruit of Chinese magnoliavine first and second C prime monomer component concentration
Technical field
The present invention relates to chromatograph Material Field, specifically a kind of method of Simultaneously test ursolic acid and the fruit of Chinese magnoliavine first and second C prime monomer component concentration.
Background technology
Traditional Chinese medicine especially natural traditional Chinese medicine multiply the mankind in several thousand, survive, develop in play an important role, and the fruit of Chinese magnoliavine, the fruit of medicinal cornel are exactly the medicinal material of this wherein outbalance.The fruit of Chinese magnoliavine is perennial fallen leaves liana, and belong to Magnoliaceae, this medicine is multiple functional, and the five tastes all have, therefore has the title of the fruit of Chinese magnoliavine.In Chinese medicinal material, the five tastes have concurrently and belong to exclusive in fact, and it has unique curative effect to the deficiency of Yin and the deficiency of yang.The fruit of Chinese magnoliavine has nourshing kidney of astringing the lung, effect of the arrest sweating that promotes the production of body fluid, puckery smart antidiarrheal, antitoxic heart-soothing and sedative.The fruit of Chinese magnoliavine is mainly containing principal ingredients such as lignanoid, volatile oil, organic acid, triterpene, sequiterpenes, and wherein Lignanoids compounds mainly comprises schizandrin A, deoxyschizandrin and schisandrin C etc.Modern pharmacology shows, fruit of Chinese magnoliavine first, second, C prime have many pharmacologically actives, and as having sedation to central nervous system, too high to chronic hepatitis, neurasthenia, gastric acidity, the diseases such as ulcer have good clinical efficacy.The fruit of medicinal cornel is deciduous tree or dungarunga, and drying and ripening pulp is used as medicine.The fruit of medicinal cornel has tonifying the liver and kidney, restrains astringent or styptic treatment for spontaneous sweating effect.The fruit of medicinal cornel is mainly containing multiple elements such as loganin, cornin, the new glycosides of the fruit of medicinal cornel, ursolic acid, oleanolic acids.Modern pharmacology shows, ursolic acid has reduction blood sugar, the effect such as anti-ageing and immunological regulation.As can be seen here, ursolic acid and fruit of Chinese magnoliavine first, second, C prime are that the Chinese medicine fruit of medicinal cornel and the fruit of Chinese magnoliavine play the most key active monomer component of pharmacological action.Therefore, the Quality Control detection method of detection fruit of Chinese magnoliavine first, second, C prime and ursolic acid is simultaneously found to ensureing that the quality of the pharmaceutical preparations is vital.
In prior art, when detecting fruit of Chinese magnoliavine first, second, C prime by reversed-phased high performace liquid chromatographic, adopt linear gradient elution method more simultaneously, selection 250nm is absorbing wavelength, owing to will convert the ratio of mobile phase in experimentation, can cause baseline fluctuation, sensitivity decrease, affects the accuracy of experimental result; And majority goes out peak after 30min, cause experimental period long.
Summary of the invention
The present invention is exactly to overcome in prior art, linear gradient elution method causes baseline fluctuation when detecting fruit of Chinese magnoliavine first, second, C prime simultaneously, sensitivity decrease, and simultaneously can not detect the shortcoming of ursolic acid and fruit of Chinese magnoliavine first, second, C prime four kinds of active monomer components, and the method for a kind of isocratic elution method Simultaneously test ursolic acid provided and the fruit of Chinese magnoliavine first and second C prime monomer component concentration.
The present invention realizes according to following technical scheme.
A method for Simultaneously test ursolic acid and the fruit of Chinese magnoliavine first and second C prime monomer component concentration, comprises the following steps:
A. the pre-service of sample
The fruit of Chinese magnoliavine, be dried to constant weight containing the ursolic acid medicinal material fruit of medicinal cornel, cross 40 mesh sieves after pulverizing, take containing the ursolic acid medicinal material fruit of medicinal cornel 10 parts by ratio of weight and the number of copies respectively, 1 part, the fruit of Chinese magnoliavine, after mixing, add 10 times amount absolute ethyl alcohols; Ultrasound wave extracts and suction filtration, and filtrate crosses 0.22 μm of miillpore filter, sample size 3-20 μ L;
Testing sample lacks the preparation containing ursolic acid medicinal material fruit of medicinal cornel negative control solution: essence claims 1 part of Chinese Magnolivine Fruit, preparation, filter, sample size is the same;
Testing sample lacks the preparation of fruit of Chinese magnoliavine negative control solution: essence claims 10 parts containing ursolic acid medicinal material Asiatic Cornelian Cherry Fruit, preparation, filter, sample size is the same;
B. high performance liquid chromatography operating conditions
Agilent 1260 type high performance liquid chromatograph; Chromatographic column: 150 × 46 mm, 5 μm, ZORBAX SB-C18; Mobile phase is acetonitrile 67-70% :0.1% phosphate aqueous solution 33-30%, volumetric flow rate is 0.8-1.2 mL/min; UV detect wavelength is 190-220 nm; Column temperature 25-40 DEG C;
The condition that ultrasound wave extracts is 250W, 40KHz, and 20 DEG C, ultrasonic time is 30min;
C. the preparation of working curve
Precision takes ursolic acid reference substance 1.36 mg, A prime reference substance 1.0 mg, deoxyschizandrin reference substance 1.36 mg, schisandrin C reference substance 0.82 mg respectively, be made into the absolute ethyl alcohol mixing reference substance solution of 1mL, and carry out doubling dilution, obtain 8 mass concentrations of four kinds of monomer mixing reference substance dilute solutions altogether, get rear 7 mass concentrations and the peak area of sample introduction mensuration and corresponding concentration drawing standard curve; Each mass concentration liquid crosses 0.22 μm of miillpore filter respectively, and sample introduction 10 μ L carries out stratographic analysis, with peak area ato concentration ccarry out linear regression, obtain four kinds of monomer component working curves simultaneously;
D. the chromatographic resolution of four kinds of monomer components and the mensuration of content
Upper machine mensuration will be carried out through the pretreated fruit of Chinese magnoliavine with containing ursolic acid medicinal material fruit of medicinal cornel sample, four kinds of monomer components carry out chromatographic resolution, and are calculated the content of four kinds of monomer components respectively by corresponding working curve according to peak area corresponding to traditional Chinese medicine monomer composition each in testing sample.
The invention has the beneficial effects as follows:
The present invention (25min) can utilize isocratic elution method in relative short time, under Same Wavelength chromatography experiment condition, detects simultaneously and is separated traditional Chinese medicine monomer composition-ursolic acid and fruit of Chinese magnoliavine first, second, the C prime with valuable pharmacological activity completely.Use the concentration of method Simultaneously test of the present invention four kinds of monomer components, baseline is steady, and peak type symmetry is attractive in appearance, fast easy, and degree of separation is high, highly sensitive, reproducible, and accurately and reliably, the recovery is high for data, provides a kind of good Quality Control detection means.
Accompanying drawing explanation
Fig. 1 is control sample high-efficient liquid phase chromatogram of the present invention;
Fig. 2 is testing sample high-efficient liquid phase chromatogram of the present invention;
Fig. 3 is the negative control solution high-efficient liquid phase chromatogram that testing sample of the present invention lacks the fruit of Chinese magnoliavine;
Fig. 4 is the negative control solution high-efficient liquid phase chromatogram that testing sample of the present invention lacks the fruit of medicinal cornel.
Embodiment
Below in conjunction with drawings and Examples, the present invention is described in detail.
1. instrument and material
2.1 instrument
Agilent 1260 type high performance liquid chromatograph, comprises quaternary pump, G1311C, automatic sampler, G1329B, VWD detecting device, G1314F, chromatographic work station, Anjelen Sci. & Tech. Inc;
AE240 precise electronic analytical balance, plum Teller-Shanghai holder benefit instrument;
Superpure water machine, French MILLIPORE;
Universalpulverizer, Beijing Zhong Xing great achievement Instrument Ltd. manufactures;
Supersonic extractors, Xin Yi biotech inc, Ningbo;
Electric drying oven with forced convection, Tianjin three hydroscience Instrument Ltd..
2.2 material
Fruit of Chinese magnoliavine first, second, C prime reference substance, Nat'l Pharmaceutical & Biological Products Control Institute, massfraction is no less than 99.9%, lot number 20130306;
Ursolic acid, Nat'l Pharmaceutical & Biological Products Control Institute, massfraction is no less than 99.9%, lot number 20130406;
Acetonitrile (chromatographically pure), German Merk company;
Phosphoric acid (chromatographically pure), Tianjin recovery fine chemistry industry research institute;
Experimental water is secondarily purified water, and Tianjin City No.1 Central Hospital pharmaceutical factory provides.
2. experimental technique and result
The pre-service of 2.1 samples
The fruit of Chinese magnoliavine, be dried to constant weight containing at the ursolic acid medicinal material fruit of medicinal cornel 60 DEG C, cross 40 mesh sieves after pulverizing, precision takes containing ursolic acid medicinal material fruit of medicinal cornel 1g respectively, and fruit of Chinese magnoliavine 0.1g, pours into the powder of mixing in 25ml conical flask, adds 1mL absolute ethyl alcohol.At 250W, 40KHz, under 20 DEG C of experiment conditions, ultrasonic extraction 30min, the ethanolic solution that suction filtration extracts, filtrate crosses 0.22 μm of miillpore filter, sample introduction 10 μ L.
Testing sample lacks the preparation containing ursolic acid medicinal material fruit of medicinal cornel negative control solution: essence claims Chinese Magnolivine Fruit 0.1g, pours in conical flask, add 1mL absolute ethyl alcohol by the powder of mixing; At 250W, 40KHz, under 20 DEG C of experiment conditions, ultrasonic extraction 30min, the ethanolic solution that suction filtration extracts, filtrate crosses 0.22 μm of miillpore filter, sample introduction 10 μ L.
Testing sample lacks the preparation of fruit of Chinese magnoliavine negative control solution: essence claims, containing ursolic acid medicinal material Asiatic Cornelian Cherry Fruit 1g, to pour in conical flask, add 10mL absolute ethyl alcohol by the powder of mixing; At 250W, 40KHz, under 20 DEG C of experiment conditions, ultrasonic extraction 30min, the ethanolic solution that suction filtration extracts, filtrate crosses 0.22 μm of miillpore filter, sample introduction 10 μ L.
2.2 chromatographic condition
Agilent 1260 type high performance liquid chromatograph; Chromatographic column: ZORBAX SB-C 18(150 × 46 mm, 5 μm) chromatographic column.Mobile phase is acetonitrile: 0.1% phosphate aqueous solution=67:33, volumetric flow rate 1.0 mL/min; UV detect wavelength is 210 nm; Column temperature 30 DEG C; Sample size 10 μ L.
The preparation of 2.3 working curves
Precision takes ursolic acid reference substance 1.36 mg, A prime reference substance 1.0 mg, deoxyschizandrin reference substance 1.36 mg, schisandrin C reference substance 0.82 mg respectively, be made into the absolute ethyl alcohol mixing reference substance solution of 1mL, and carry out doubling dilution, obtain 8 mass concentrations of four kinds of monomer mixing reference substance dilute solutions, get rear 7 mass concentrations and the peak area that measures of sample introduction and corresponding concentration obtain the working curve of four kinds of monomer components simultaneously.
2.3.1 ursolic acid working curve
In each 8 mass concentrations of the four kinds of monomer mixing reference substance dilute solutions obtained, the mass concentration obtaining ursolic acid dilute solution is 680,340,170,85,42.5,21.25,10.625,5.313 mg/L; Get rear 7 mass concentrations and the peak area of sample introduction mensuration and corresponding concentration drawing standard curve; Each mass concentration liquid crosses 0.22 μm of miillpore filter respectively, and sample introduction 10 μ L carries out stratographic analysis; With peak area ato concentration c(mg/L) carry out linear regression, obtain ursolic acid working curve: A=6.135C+18.700, r=0.9995; Ursolic acid is good linear relationship with peak area between mass concentration 340 ~ 5.313 mg/L; According to signal to noise ratio (S/N ratio) 3/1, ursolic acid lowest detection mass concentration is 0.025 mg/L.
2.3.2 schizandrin A working curve
In each 8 mass concentrations of the four kinds of monomer mixing reference substance dilute solutions obtained, the mass concentration obtaining schizandrin A dilute solution is 500,250,125,62.5,31.25,15.625,7.812,3.906 mg/L; Get rear 7 mass concentrations and the peak area of sample introduction mensuration and corresponding concentration drawing standard curve; Each mass concentration liquid crosses 0.22 μm of miillpore filter respectively, and sample introduction 10 μ L carries out stratographic analysis; With peak area ato concentration c(mg/L) carry out linear regression, obtain schizandrin A working curve: A=79.196C+196.449, r=0.9994; Schizandrin A is good linear relationship with peak area between mass concentration 250 ~ 3.906 mg/L; According to signal to noise ratio (S/N ratio) 3/1, the lowest detection mass concentration of schizandrin A is 0.016 mg/L.
2.3.3 deoxyschizandrin working curve
In each 8 mass concentrations of the four kinds of monomer mixing reference substance dilute solutions obtained, the mass concentration obtaining deoxyschizandrin dilute solution is 680,340,170,85,42.5,21.25,10.625,5.313 mg/L; Get rear 7 mass concentrations and the peak area that records of sample introduction and corresponding concentration drawing standard curve; Each mass concentration liquid crosses 0.22 μm of miillpore filter respectively, and sample introduction 10 μ L carries out stratographic analysis; With peak area ato concentration c(mg/L) carry out linear regression, obtain deoxyschizandrin working curve: A=22.085C+66.829, r=0.9995; Deoxyschizandrin is good linear relationship with peak area between mass concentration 340 ~ 5.313 mg/L; According to signal to noise ratio (S/N ratio) 3/1, the lowest detection mass concentration of deoxyschizandrin is 0.019 mg/L.
2.3.4 schisandrin C working curve
In each 8 mass concentrations of the four kinds of monomer mixing reference substance dilute solutions obtained, the mass concentration obtaining schisandrin C dilute solution is 410,205,102.5,51.25,25.625,12.810,6.450,3.225 mg/L; Get rear 7 mass concentrations and the peak area that records of sample introduction and corresponding concentration drawing standard curve; Each mass concentration liquid crosses 0.22 μm of miillpore filter respectively, and sample introduction 10 μ L carries out stratographic analysis; With peak area ato concentration c(mg/L) carry out linear regression, obtain schisandrin C working curve: A=23.106C+43.569, r=0.9995; Schisandrin C is good linear relationship with peak area between mass concentration 205 ~ 3.225 mg/L; According to signal to noise ratio (S/N ratio) 3/1, the lowest detection mass concentration of schisandrin C is 0.020 mg/L.
2.4 chromatographic resolution
Respectively chromatographic resolution is carried out to the ursolic acid in sample to be tested and fruit of Chinese magnoliavine first, second, C prime, the results are shown in Figure 1, in 2(figure: 1: schizandrin A; 2: deoxyschizandrin; 3: schisandrin C; 4: ursolic acid).Visible, the separation of each component all can reach baseline separation, and peak type is symmetrical, and degree of separation is good, and disturbs without obvious impurity peaks.The retention time of ursolic acid is 23.003 min; The retention time of schizandrin A is 10.401 min; The retention time of deoxyschizandrin is 13.329 min; The retention time of schisandrin C is 15.388 min.
Do the negative control experiment that sample to be tested lacks the fruit of Chinese magnoliavine and the fruit of medicinal cornel respectively respectively, the results are shown in Figure 3 and 4.Visible, Fig. 3 does not detect the chromatographic peak of these three kinds of monomer components in fruit of Chinese magnoliavine first, second, the corresponding retention time of C prime; Fig. 4 does not detect its chromatographic peak in the corresponding retention time of ursolic acid.Illustrate detect this four kinds of monomer components time do not have Interference Peaks to occur.
2.5 precision tests (RSD)
To the same mixing contrast solution that schizandrin A concentration is 15.620 mg/L, deoxyschizandrin concentration is 21.25 mg/L, schisandrin C concentration is 25.625 mg/L, ursolic acid concentration is 21.25 mg/L, continuous sample introduction 5 times, record the chromatographic peak area numerical value of corresponding monomer component respectively, and through statistical procedures, measure that ursolic acid RSD is 1.86%, schizandrin A RSD is 1.76%, deoxyschizandrin RSD is 1.69%, schisandrin C RSD is 1.80%(n=5).
2.6 replica test
Prepare 6 parts of product to be tested solution according to the preparation method of above-mentioned product to be tested simultaneously, sample introduction 1 time respectively, record the chromatographic peak area numerical value of corresponding monomer component, and through statistical procedures method, ursolic acid RSD is 1.56%, schizandrin A RSD is 1.77%, deoxyschizandrin RSD is 1.66%, schisandrin C RSD is 1.49%(n=6).
2.7 mean sample recovery rate tests
In 0.9 mL sample to be tested solution, (detecting ursolic acid mass concentration is 1.635 mg/L; Schizandrin A is 1.361mg/L; Deoxyschizandrin is 9.238mg/L; Schisandrin C is 0.953mg/L) add 0.1 mL mixing reference substance solution respectively, ursolic acid mass concentration is respectively 10.625,21.25,42.5 mg/L; Schizandrin A mass concentration is respectively 7.812,15.620,31.25 mg/L; Deoxyschizandrin mass concentration is respectively 10.625,21.25,42.5 mg/L; Schisandrin C mass concentration is respectively 6.406,12.813,25,625 mg/L.Sample introduction records its mass concentration, calculates its recovery, and result ursolic acid average recovery rate is 101.16%, RSD is 1.36%; Schizandrin A average recovery rate is 100.79%, RSD is 1.41%; Deoxyschizandrin average recovery rate is 101.09%, RSD is 1.49%; Schisandrin C average recovery rate is 101.26%, RSD is 1.31%.
2.8 stability test
Same sample to be tested is measured relevant corresponding chromatogram value at 0,4,8,12,24,48 h respectively.The RSD of result ursolic acid is 1.56%; The RSD of schizandrin A is 1.61%; The RSD of deoxyschizandrin is 1.39%; The RSD of schisandrin C is 1.60%.In display sample to be tested 48 h, sample is stablized.
The mensuration of 2.9 sample to be tested content
Record the amount of ursolic acid and fruit of Chinese magnoliavine first, second in 5 samples to be tested, C prime respectively, the results are shown in Table 1.
Ursolic acid and the fruit of Chinese magnoliavine first and second C prime assay (mg/g) in table 1. sample to be tested
In sum, application the present invention (25min) can utilize isocratic elution method in relative short time, under Same Wavelength chromatography experiment condition, detect simultaneously and be separated traditional Chinese medicine monomer composition-ursolic acid and fruit of Chinese magnoliavine first, second, the C prime with valuable pharmacological activity completely.Use method of the present invention to measure the concentration of four kinds of monomer components, baseline is steady, and peak type symmetry is attractive in appearance, fast easy, and degree of separation is high, highly sensitive, reproducible, and accurately and reliably, the recovery is high for data, provides a kind of good Quality Control detection means.

Claims (5)

1. a method for Simultaneously test ursolic acid and the fruit of Chinese magnoliavine first and second C prime monomer component concentration, is characterized in that: comprise the following steps:
A. the pre-service of sample
The fruit of Chinese magnoliavine, be dried to constant weight containing the ursolic acid medicinal material fruit of medicinal cornel, cross 40 mesh sieves after pulverizing, take containing the ursolic acid medicinal material fruit of medicinal cornel 10 parts by ratio of weight and the number of copies respectively, 1 part, the fruit of Chinese magnoliavine, after mixing, add 10 times amount absolute ethyl alcohols; Ultrasound wave extracts and suction filtration, and filtrate crosses 0.22 μm of miillpore filter, sample size 3-20 μ l;
Testing sample lacks the preparation containing ursolic acid medicinal material fruit of medicinal cornel negative control solution: essence claims 1 part of Chinese Magnolivine Fruit, preparation, filter, sample size is the same;
Testing sample lacks the preparation of fruit of Chinese magnoliavine negative control solution: essence claims 10 parts containing ursolic acid medicinal material Asiatic Cornelian Cherry Fruit, preparation, filter, sample size is the same;
B. high performance liquid chromatography operating conditions
Agilent 1260 type high performance liquid chromatograph; Chromatographic column: 150 × 46 mm, 5 μm, ZORBAX SB-C18; Mobile phase is acetonitrile 67-70% :0.1% phosphate aqueous solution 33-30%, volumetric flow rate is 0.8-1.2 mL/min; UV detect wavelength is 190-220 nm; Column temperature 25-40 DEG C;
The condition that ultrasound wave extracts is 250W, 40KHz, and 20 DEG C, ultrasonic time is 30min;
C. the preparation of working curve
Precision takes ursolic acid reference substance 1.36 mg, A prime reference substance 1.0 mg, deoxyschizandrin reference substance 1.36 mg, schisandrin C reference substance 0.82 mg respectively, be made into the absolute ethyl alcohol mixing reference substance solution of 1mL, and carry out doubling dilution, obtain 8 mass concentrations of four kinds of monomer mixing reference substance dilute solutions altogether, get peak area and the corresponding concentration drawing standard curve of rear 7 mass concentration sample introductions mensuration; Each mass concentration liquid crosses 0.22 μm of miillpore filter respectively, and sample introduction 10 μ L carries out stratographic analysis, with peak area ato concentration ccarry out linear regression, obtain four kinds of monomer component working curves simultaneously;
D. the chromatographic resolution of four kinds of monomer components and the mensuration of content
Upper machine mensuration will be carried out through the pretreated fruit of Chinese magnoliavine with containing ursolic acid medicinal material fruit of medicinal cornel sample, four kinds of monomer components carry out chromatographic resolution, and are calculated the content of four kinds of monomer components respectively by corresponding working curve according to peak area corresponding to traditional Chinese medicine monomer composition each in testing sample.
2. the method for a kind of Simultaneously test ursolic acid according to claim 1 and the fruit of Chinese magnoliavine first and second C prime monomer component concentration, it is characterized in that: in four kinds of monomer mixing reference substance dilute solutions, 8 mass concentrations obtaining ursolic acid dilute solution are respectively 680,340,170,85,42.5,21.25,10.625,5.313 mg/L; Get rear 7 mass concentrations and sample introduction measure peak area and corresponding concentration obtain ursolic acid working curve: A=6.135C+18.700, r=0.9995;
Ursolic acid is good linear relationship with peak area between mass concentration 340 ~ 5.313 mg/L; According to signal to noise ratio (S/N ratio) 3/1, ursolic acid lowest detection mass concentration is 0.025 mg/L.
3. the method for a kind of Simultaneously test ursolic acid according to claim 1 and the fruit of Chinese magnoliavine first and second C prime monomer component concentration, it is characterized in that: in four kinds of monomer mixing reference substance dilute solutions, 8 mass concentrations obtaining schizandrin A dilute solution are respectively 500,250,125,62.5,31.25,15.625,7.812,3.906 mg/L; Get rear 7 mass concentrations and sample introduction measure peak area and corresponding concentration obtain schizandrin A working curve: A=79.196C+196.449, r=0.9994;
Schizandrin A is good linear relationship with peak area between mass concentration 250 ~ 3.906 mg/L; According to signal to noise ratio (S/N ratio) 3/1, the lowest detection mass concentration of schizandrin A is 0.016 mg/L.
4. the method for ursolic acid and the fruit of Chinese magnoliavine first and second C prime in a kind of Simultaneously test fruit of medicinal cornel according to claim 1, it is characterized in that: in four kinds of monomer mixing reference substance dilute solutions, 8 mass concentrations obtaining deoxyschizandrin dilute solution are respectively 680,340,170,85,42.5,21.25,10.625,5.313 mg/L; Get rear 7 mass concentrations and sample introduction measure peak area and corresponding concentration obtain deoxyschizandrin working curve: A=22.085C+66.829, r=0.9995;
Deoxyschizandrin is good linear relationship with peak area between mass concentration 340 ~ 5.313 mg/L; According to signal to noise ratio (S/N ratio) 3/1, the lowest detection mass concentration of deoxyschizandrin is 0.019 mg/L.
5. the method for ursolic acid and the fruit of Chinese magnoliavine first and second C prime in a kind of Simultaneously test fruit of medicinal cornel according to claim 1, is characterized in that: in four kinds of monomer mixing reference substance dilute solutions ,8 mass concentrations obtaining schisandrin C dilute solution are respectively 410,205,102.5,51.25,25.625,12.810,6.450,3.225 mg/L; Get rear 7 mass concentrations and sample introduction measure peak area and corresponding concentration obtain schisandrin C working curve: A=23.106C+43.569, r=0.9995;
Schisandrin C is good linear relationship with peak area between mass concentration 205 ~ 3.225 mg/L; According to signal to noise ratio (S/N ratio) 3/1, the lowest detection mass concentration of schisandrin C is 0.020 mg/L.
CN201510036874.7A 2015-01-26 2015-01-26 The method simultaneously measuring ursolic acid and Fructus Schisandrae Chinensis the first and second C primes monomer component concentration Expired - Fee Related CN104569275B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510036874.7A CN104569275B (en) 2015-01-26 2015-01-26 The method simultaneously measuring ursolic acid and Fructus Schisandrae Chinensis the first and second C primes monomer component concentration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510036874.7A CN104569275B (en) 2015-01-26 2015-01-26 The method simultaneously measuring ursolic acid and Fructus Schisandrae Chinensis the first and second C primes monomer component concentration

Publications (2)

Publication Number Publication Date
CN104569275A true CN104569275A (en) 2015-04-29
CN104569275B CN104569275B (en) 2017-03-08

Family

ID=53085833

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510036874.7A Expired - Fee Related CN104569275B (en) 2015-01-26 2015-01-26 The method simultaneously measuring ursolic acid and Fructus Schisandrae Chinensis the first and second C primes monomer component concentration

Country Status (1)

Country Link
CN (1) CN104569275B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030026854A1 (en) * 2001-04-04 2003-02-06 Xinxian Zhao Plant drug for treatment of liver disease
CN1836717A (en) * 2004-12-13 2006-09-27 贵阳云岩西创药物科技开发有限公司 Quality controlling method for pulse restoring injection
CN1911393A (en) * 2005-08-12 2007-02-14 北京联合西创药物科技有限公司 Injection contg. traditional Chinese medicine, and its quality control method
CN101709059A (en) * 2009-12-09 2010-05-19 北京博远欣绿科技有限公司 Chinese magnoliavine fruit monomer composition separation preparation method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030026854A1 (en) * 2001-04-04 2003-02-06 Xinxian Zhao Plant drug for treatment of liver disease
CN1836717A (en) * 2004-12-13 2006-09-27 贵阳云岩西创药物科技开发有限公司 Quality controlling method for pulse restoring injection
CN1911393A (en) * 2005-08-12 2007-02-14 北京联合西创药物科技有限公司 Injection contg. traditional Chinese medicine, and its quality control method
CN101709059A (en) * 2009-12-09 2010-05-19 北京博远欣绿科技有限公司 Chinese magnoliavine fruit monomer composition separation preparation method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Y. H. CHOI等: "Optimum SFE Condition for Lignans of Schisandra chinensis Fruits", 《CHROMATOGRAPHIA》 *
洪海等: "高效液相色谱法测定强肝消脂胶囊中熊果酸的含量", 《中国医药指南》 *

Also Published As

Publication number Publication date
CN104569275B (en) 2017-03-08

Similar Documents

Publication Publication Date Title
CN103869003B (en) Cortex Phellodendri medical material solvent pairs merges method for building up and the standard finger-print thereof of HPLC finger printing
CN109596751A (en) A kind of Mailuo Ning oral liquid component detection method of clearing heat and nourishing yin promoting blood circulation
WO2023024322A1 (en) Method for determining fingerprint of traditional chinese medicine composition
CN108459090B (en) Quality control method of Jichuan decoction composition
CN103808835A (en) Method for simultaneously measuring contents of 10 chemical components in four-substance soup decoction by HPLC-DAD (high performance liquid chromatography-diode array detection) method
CN112666277B (en) HPLC (high Performance liquid chromatography) characteristic spectrum construction and detection method for rhizoma cyperi medicinal materials, decoction pieces, standard decoction and formula granules
CN104007198B (en) A kind of glossy ganoderma emperor's preparation HPLC standard finger-print and construction method thereof and application
CN109632997A (en) The extraction and measuring method of regallity glycosides B in a kind of lily medicinal material
CN110108827B (en) Method for simultaneously determining eight active ingredients in antipyretic and antitoxic tablet
CN110927302B (en) Method for measuring fingerprint of collateral-dredging phlegm-reducing capsule
CN112684036A (en) Fingerprint spectrum determination method of kidney-tonifying capsules containing leeches and application of fingerprint spectrum determination method
CN105699510B (en) The content assaying method of Kaempferitrin in a kind of thick wood-fern rhizome medicinal material
CN104614475A (en) Thirst quenching clearing particle content detection method
CN103389353A (en) Ultra-high performance liquid chromatography method for determination of content of phenolic acid components in blood-nourishing cephalocathartic particles
CN113341007B (en) HPLC (high Performance liquid chromatography) characteristic spectrum-based method for measuring content of all ingredients of jujube kernel nerve-soothing capsules
CN101816753A (en) Method for detecting quality of compound preparation for treating cold
CN107748219A (en) A kind of assay method of naoxueshu preparations finger-print
CN105067725B (en) It is a kind of at the same determine shenmei stomach nourishing granule in the root of herbaceous peony, radix glycyrrhizae and the red sage root content method
CN109932437A (en) A kind of detection method of pharmaceutical composition
CN110687219B (en) Detection method of suhuang cough-relieving capsule fingerprint and application thereof
CN104569275A (en) Method for simultaneously measuring concentrations of monomer components including ursolic acid, schizandrin a, schizandrin b and schizandrin c
CN108982731B (en) Method for constructing HPLC characteristic spectrum of sarcandra glabra buccal tablet and HPLC characteristic spectrum thereof
CN106501397A (en) The method for building up for the treatment of osteoporosis preparation HPLC fingerprint pattern and purposes
CN102008541A (en) Method for simultaneously detecting three main active ingredients in sugar-free type compound wintercreeper preparation
CN105203469A (en) Detection method of medicament for treating femoral head necrosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170308

Termination date: 20190126

CF01 Termination of patent right due to non-payment of annual fee